(Q33935724)

30 July 2017

1 reference

title

Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect". (English)

1 reference

30 July 2017

Braunholtz DA

1

1 reference

PubMed ID

11223318

30 July 2017

Edwards SJ

series ordinal

2

1 reference

PubMed ID

11223318

30 July 2017

Lilford RJ

series ordinal

3

1 reference

30 July 2017

1 March 2001

1 reference

Journal of Clinical Epidemiology

30 July 2017

1 reference

30 July 2017

54

1 reference

30 July 2017

3

1 reference

30 July 2017

217-224

1 reference

Centralised treatment, entry to trials and survival

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Are randomized control trial outcomes influenced by the inclusion of a placebo group?: a systematic review of nonsteroidal antiinflammatory drug trials for arthritis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Randomized versus historical controls for clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

What is the prior probability of a proposed new treatment being superior to established treatments?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Epidemiologic analyses of causation: the unlearned scientific lessons of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Analysis of randomized and nonrandomized patients in clinical trials using the comprehensive cohort follow-up study design

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Randomised study of n of 1 trials versus standard practice

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Protocol allocation and exclusion in two Danish randomised trials in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Do treatment protocols improve end results? A study of survival of patients with multiple myeloma in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Survival from acute non-lymphocytic leukaemia, 1971-88: a population based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients. The British Stomach Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

The value of participating in an asthma trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Comparison of eligible randomized patients with two groups of ineligible patients: can the results of the VA Total Parenteral Nutrition clinical trial be generalized?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

Redressing the balance--the ethics of not entering an eligible patient on a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900305-X

7 January 2021

10.1016/S0895-4356(00)00305-X

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11223318